CDNA | CareDxNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$85.88
-$1.53 (-1.75%)

CareDx (CDNA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Dec 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $85.88 vs 50 $60.67 / 200 $33.97
Projection
No cross projected
Test
No active test
Last cross
Golden cross 16 Dec 2025 ยท projected 24 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $87.41 vs 50 $31.59 / 200 $19.04
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 2 Jun 2025 ยท projected 26 bars out ยท tested 2 bars

4-hour as of 3 Nov 16:00 ET

Price
above both $88.47 vs 50 $69.52 / 200 $48.84
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 May 2026 ยท projected 16 bars out

Cross history

22
crosses on record since 2017
12 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 May 2026Golden4-hour16 bars outNot tested
20 Mar 2026Death4-hour25 bars out2 bar cross test
16 Dec 2025Golden moderatedaily24 bars outNot tested
7 Nov 2025Golden4-hour30 bars outNot tested
24 Jul 2025Death4-hour7 bars outโ€”

About CDNA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$65.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.